SHL Telemedicine Ltd. (SWX:SHLTN)
Switzerland · Delayed Price · Currency is CHF 1.100
+0.030 (2.80%)
Jan 30, 2026, 5:30 PM CET
SHL Telemedicine Market Cap
SHL Telemedicine has a market cap or net worth of 40.76 million as of January 30, 2026. Its market cap has decreased by -8.57% in one year.
Market Cap
40.76M
Enterprise Value
41.79M
Revenue
45.19M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.10
Market Cap Chart
Since November 14, 2000, SHL Telemedicine's market cap has decreased from 229.59M to 40.76M, a decrease of -82.24%. That is a compound annual growth rate of -6.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2026 | 39.65M | -9.32% |
| Dec 30, 2025 | 43.73M | 2.61% |
| Dec 30, 2024 | 42.62M | -62.59% |
| Dec 29, 2023 | 113.92M | -47.37% |
| Dec 30, 2022 | 216.45M | -21.67% |
| Dec 30, 2021 | 276.35M | 121.10% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 295.96B |
| Novartis AG | 219.28B |
| Lonza Group AG | 37.50B |
| Galderma Group AG | 33.93B |
| Ascom Holding AG | 192.88M |
| Santhera Pharmaceuticals Holding AG | 177.93M |
| BioVersys AG | 140.94M |
| Xlife Sciences AG | 127.46M |